Method of using diketopiperazines and composition containing them
The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R 1 and R 2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.
1. A method of treating a respiratory condition selected from the group consisting of acute respiratory distress syndrome, bronchitis, cystic fibrosis, emphysema and respiratory infection, comprising administering to an animal in need thereof an effective amount of a compound of the formula:
wherein:
R 1 is CH 2 COOH;
R 2 is the side chain of alanine;
or
a physiologically-acceptable salt thereof.
2. The method of claim 1 , wherein the compound is administered as a pharmaceutical formulation.
3. The method of claim 2 , wherein the pharmaceutical formulation is formulated for administration by inhalation.
4. The method of claim 3 , wherein the formulation is a liquid, spray, drops, or dry powder.
5. A method of treating a respiratory condition selected from the group consisting of acute respiratory distress syndrome, bronchitis, cystic fibrosis, emphysema and respiratory infection comprising administering to an animal in need thereof, a pharmaceutical composition, wherein the pharmaceutical composition comprises 3-methyl-2,5-diketopiperazine-6-acetic acid and is formulated for administration by inhalation.